Page last updated: 2024-10-30

lansoprazole and Neuroendocrine Tumors

lansoprazole has been researched along with Neuroendocrine Tumors in 1 studies

Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.

Neuroendocrine Tumors: Tumors whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumors include ectopic hormone production (often via APUD CELLS), the presence of tumor-associated antigens, and isozyme composition.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tsukamoto, H1
Mizoshita, T1
Sasaki, M1
Mizushima, T1
Tanida, S1
Ozeki, K1
Hirata, Y1
Shimura, T1
Kataoka, H1
Kamiya, T1
Nojiri, S1
Tsukamoto, T1
Tatematsu, M1
Joh, T1

Other Studies

1 other study available for lansoprazole and Neuroendocrine Tumors

ArticleYear
Long-term high-dose proton pump inhibitor administration to Helicobacter pylori-infected Mongolian gerbils enhances neuroendocrine tumor development in the glandular stomach.
    Asian Pacific journal of cancer prevention : APJCP, 2011, Volume: 12, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Carcinoma; Cell Transformation, Neoplastic; Chromo

2011